Ingo Schmitz

15.3k total citations · 2 hit papers
112 papers, 5.2k citations indexed

About

Ingo Schmitz is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ingo Schmitz has authored 112 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 48 papers in Immunology and 18 papers in Cancer Research. Recurrent topics in Ingo Schmitz's work include Cell death mechanisms and regulation (36 papers), Immune Cell Function and Interaction (18 papers) and NF-κB Signaling Pathways (16 papers). Ingo Schmitz is often cited by papers focused on Cell death mechanisms and regulation (36 papers), Immune Cell Function and Interaction (18 papers) and NF-κB Signaling Pathways (16 papers). Ingo Schmitz collaborates with scholars based in Germany, United States and France. Ingo Schmitz's co-authors include Peter H. Krammer, Marcus E. Peter, Carsten Scaffidi, Sabine Kirchhoff, Andreas Krueger, Klaus Schulze‐Osthoff, Sven Baumann, Marc Schuster, Stanley J. Korsmeyer and Jiping Zha and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Ingo Schmitz

107 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of c-FLIP in Modulation of CD95-induced Apoptosis

1999 687 citations Ingo Schmitz, Peter H. Krammer et al. profile →
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells

1999 523 citations Ingo Schmitz, Peter H. Krammer et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ingo Schmitz	3.3k	1.8k	921	768	764	112	5.2k
Shingo Miyamoto	2.4k 0.7×	762 0.4×	1.1k 1.2×	211 0.3×	708 0.9×	199	5.5k
Robert J. Lutz	4.2k 1.3×	988 0.5×	3.2k 3.4×	648 0.8×	463 0.6×	116	8.7k
Giuseppe D’Alessio	3.0k 0.9×	756 0.4×	498 0.5×	99 0.1×	116 0.2×	147	4.2k
Peter N. Kao	2.6k 0.8×	519 0.3×	265 0.3×	477 0.6×	394 0.5×	71	5.0k
Reiko Ito	1.5k 0.5×	702 0.4×	775 0.8×	405 0.5×	408 0.5×	126	3.7k
Akira Hayashi	1.4k 0.4×	742 0.4×	308 0.3×	226 0.3×	105 0.1×	137	3.4k
Hua‐Lin Wu	1.6k 0.5×	538 0.3×	383 0.4×	633 0.8×	787 1.0×	166	4.4k
Michael J. Wilson	870 0.3×	1000 0.6×	381 0.4×	206 0.3×	647 0.8×	112	3.1k
Håkan Pertoft	1.9k 0.6×	583 0.3×	334 0.4×	586 0.8×	280 0.4×	81	4.8k
Roland Hartig	1.5k 0.5×	1.4k 0.8×	516 0.6×	229 0.3×	343 0.4×	107	4.5k

Countries citing papers authored by Ingo Schmitz

Since Specialization

Citations

This map shows the geographic impact of Ingo Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Schmitz more than expected).

Fields of papers citing papers by Ingo Schmitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Schmitz. The network helps show where Ingo Schmitz may publish in the future.

Co-authorship network of co-authors of Ingo Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Schmitz. A scholar is included among the top collaborators of Ingo Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Schmitz. Ingo Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stüve, Philipp, Fatima Boukhallouk, Tushar H. More, et al.. (2025). ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance. Molecular Metabolism. 94. 102111–102111. 8 indexed citations

Plaza‐Sirvent, Carlos, Marc Schuster, Marco Preußner, et al.. (2024). The nuclear GYF protein CD2BP2/U5–52K is required for T cell homeostasis. Frontiers in Immunology. 15. 1415839–1415839. 2 indexed citations

Pásztói, Mária, Tilo Biedermann, Ingo Schmitz, et al.. (2024). The atypical IκB family member Bcl3 determines differentiation and fate of intestinal RORγt+ regulatory T-cell subsets. Mucosal Immunology. 17(4). 673–691. 2 indexed citations

Luu, Maik, Hanna Leister, Yoav D. Shaul, et al.. (2024). Dissecting the metabolic signaling pathways by which microbial molecules drive the differentiation of regulatory B cells. Mucosal Immunology. 18(1). 66–75. 2 indexed citations

Wacker, Max, Anna Ball, Hans‐Dietmar Beer, et al.. (2023). Immunophenotyping of Monocyte Migration Markers and Therapeutic Effects of Selenium on IL-6 and IL-1β Cytokine Axes of Blood Mononuclear Cells in Preoperative and Postoperative Coronary Artery Disease Patients. International Journal of Molecular Sciences. 24(8). 7198–7198. 4 indexed citations

Schmitz, Ingo & Sabrina Mühlen. (2023). An innate immune sensor wandering around – NOD1 promotes cell migration via non‐canonical signaling. FEBS Journal. 290(22). 5292–5294.

Faissner, Simon, Carlos Plaza‐Sirvent, Ilya Ayzenberg, et al.. (2022). Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination. Therapeutic Advances in Neurological Disorders. 15. 4213422593–4213422593. 3 indexed citations

Hartig, Roland, Carlos Plaza‐Sirvent, Ingo Schmitz, et al.. (2022). Y192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection. International Journal of Molecular Sciences. 23(13). 7271–7271. 6 indexed citations

Mühlen, Sabrina, et al.. (2021). Autophagy—A Story of Bacteria Interfering with the Host Cell Degradation Machinery. Pathogens. 10(2). 110–110. 33 indexed citations

10.

Plaza‐Sirvent, Carlos, Bei Zhao, Marina C. Pils, et al.. (2021). A Central Role for Atg5 in Microbiota-Dependent Foxp3+ RORγt+ Treg Cell Preservation to Maintain Intestinal Immune Homeostasis. Frontiers in Immunology. 12. 705436–705436. 7 indexed citations

11.

Göbel, Ulrich, et al.. (2020). Sensor system for long-term analysis of fuel vapour restraint systems. tm - Technisches Messen. 87(5). 304–311. 1 indexed citations

12.

Katsoulis‐Dimitriou, Konstantinos, et al.. (2019). Essential role of IκB _NS for in vivo CD4 ⁺ T‐cell activation, proliferation, and Th1‐cell differentiation during Listeria monocytogenes infection in mice. European Journal of Immunology. 49(9). 1391–1398. 9 indexed citations

13.

Bou‐Hanna, Chantal, Anne Jarry, Laurence Lodé, et al.. (2015). Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis. Cancer Letters. 359(2). 211–217. 38 indexed citations

14.

Schulz, Wolfgang A., et al.. (2014). Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer. International Journal of Molecular Sciences. 15(11). 20500–20517. 21 indexed citations

15.

Hildebrand, Dominic G., Eva Alexander, Simon Lehle, et al.. (2013). I kappa B zeta Is a Transcriptional Key Regulator of CCL2/MCP-1. The Journal of Immunology. 190(9). 3 indexed citations

16.

Telieps, Tanja, Marcus Gereke, Marc Schuster, et al.. (2013). Cellular‐FLIP, Raji isoform (c‐FLIP_R) modulates cell death induction upon T‐cell activation and infection. European Journal of Immunology. 43(6). 1499–1510. 13 indexed citations

17.

Schmitz, Ingo, Wataru Ariyoshi, Nobunori Takahashi, Cheryl B. Knudson, & Warren Knudson. (2009). Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways. Osteoarthritis and Cartilage. 18(3). 447–454. 16 indexed citations

18.

Schmitz, Ingo, Heiko Weyd, Andreas Krueger, et al.. (2004). Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort. The Journal of Immunology. 172(4). 2194–2200. 72 indexed citations

19.

Schmitz, Ingo, Andreas Krueger, Sven Baumann, et al.. (2003). An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death. The Journal of Immunology. 171(6). 2930–2936. 54 indexed citations

20.

Kirchhoff, Sabine, Wolfgang W. Müller, Andreas Krueger, Ingo Schmitz, & Peter H. Krammer. (2000). TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity. The Journal of Immunology. 165(11). 6293–6300. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact